Merck & Co., Inc. (MRK)
109.45
+0.62
(+0.57%)
USD |
NYSE |
Jan 20, 16:00
110.00
+0.55
(+0.50%)
Pre-Market: 05:52
Merck Research and Development Expense (TTM): 14.26B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Gilead Sciences, Inc. | 5.734B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Cidara Therapeutics, Inc. | 131.82M |
| Moderna, Inc. | 3.271B |